This HTML5 document contains 206 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://dx.doi.org/10.1038/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36907216
rdf:type
wikibase:Item
schema:description
2016年論文 videnskabelig artikel artículo científico publicado en 2016 artikel ilmiah artigo científico scienca artikolo articol științific 2016年论文 บทความทางวิทยาศาสตร์ 2016年論文 article científic научни чланак научна статия наукова стаття, опублікована в травні 2016 artikull shkencor bilimsel makale 2016年论文 scientific article published on 13 May 2016 2016年論文 naučni članak tudományos cikk tieteellinen artikkeli vitenskapelig artikkel სამეცნიერო სტატია article scientific 2016年论文 مقالة علمية نشرت في 13 مايو 2016 2016年論文 vitskapeleg artikkel 2016年论文 2016年の論文 2016年论文 мақолаи илмӣ научная статья 2016 nî lūn-bûn bài báo khoa học artykuł naukowy artikulong pang-agham artigo científico 2016년 논문 wetenschappelijk artikel scientific article published on 13 May 2016 vetenskaplig artikel מאמר מדעי teaduslik artikkel articolo scientifico wissenschaftlicher Artikel artículu científicu espublizáu en 2016 2016年论文 scientific article published on 13 May 2016 научни чланак 2016年論文 vědecký článek vedecký článok artigo científico επιστημονικό άρθρο ১৩ মে ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique
p:P577
wds:Q36907216-0B265EEE-6BC5-4A0F-BFA8-BEFAB265C20D
wdt:P577
2016-05-13T00:00:00Z
p:P2888
wds:Q36907216-B4420696-387B-49C2-9F6C-21915437D7A5
wdt:P2888
n8:ncomms11579
p:P2860
wds:Q36907216-5EF1BC4C-1B2C-4181-932E-C3629417CCCC wds:Q36907216-66407C67-010A-4AA8-A361-F3CFECC1F054 wds:Q36907216-752279A4-2D59-4DF6-A0A7-417773E8B083 wds:Q36907216-7C06BF48-967F-4F42-A5E9-7E87587BB4F3 wds:Q36907216-853A7AC8-00A5-472E-8A7F-5F6BD735BE0C wds:Q36907216-42A6EA15-FDAD-489A-BF93-50A4395DAEE5 wds:Q36907216-4BF7E0CC-CAF7-49B7-B940-8D54836791FF wds:Q36907216-4E74EACF-690D-453E-A025-4B9C2918569E wds:Q36907216-4EA7E244-E51C-40EC-B7D9-54BDF5DD6017 wds:Q36907216-5A7BBBCE-5680-44A1-9E51-6B9EE4949231 wds:Q36907216-1FE0994E-B503-444D-A83D-B8A9D2500F4C wds:Q36907216-24C816A0-AED4-4472-A5AB-5668584BEAFA wds:Q36907216-278910C1-955C-4D66-8825-A1A8FD1021F1 wds:Q36907216-28014169-6689-4E67-8F75-A7065682D8D6 wds:Q36907216-3B30721A-F4EF-4C1A-A34F-D1367512CD8C wds:Q36907216-405C1CD3-79B9-41AF-94AC-B586CF3B69B2 wds:Q36907216-0BC66A3C-FFBF-498C-BB9C-6DED0B44ECE6 wds:Q36907216-0C02EA90-07BE-490A-9F9E-37E1D0019AF9 wds:Q36907216-0EF5F1BF-543E-4B81-9F53-9230EF960C46 wds:Q36907216-1304593D-8F49-48CE-8C44-A5ED676A940F wds:Q36907216-1383DAEF-E697-4570-B265-5A8C2ED5FBBC wds:Q36907216-028A8F9B-83F1-420F-8EDE-87B8C5BD8233 wds:Q36907216-0682828F-D62C-4242-BC53-8943EB8183C6 wds:Q36907216-EB8D8FA5-8B2E-457D-8D83-41C340EF5B04 wds:Q36907216-ED2A9648-8F9A-41D8-919B-5056A0022FA5 wds:Q36907216-EE0D98E2-5755-4843-8594-7D5994BA0B4F wds:Q36907216-F261FDB3-CF43-43E0-8039-FCDEC31C8FE1 wds:Q36907216-F9A11093-E032-408B-8E3C-CB2682F4A425 wds:Q36907216-D88523ED-258C-49D7-B525-F9FB8894F1BD wds:Q36907216-E24BF665-71A5-4A91-A327-8D45183B2040 wds:Q36907216-E6A61915-A4D2-4454-9AF7-C08AF4E1893C wds:Q36907216-B75141C6-08DC-431F-A451-42E0B81D3931 wds:Q36907216-CA22512C-96D7-447D-80DA-A993888C7068 wds:Q36907216-CD6282CB-987C-4787-B33D-B5F967E9F209 wds:Q36907216-CF0C1779-2479-4214-95C6-DBC00930A7A1 wds:Q36907216-8D2A3457-D5F6-4EF2-9086-48D6FA62BA01 wds:Q36907216-A6E4A78E-E019-4ED3-88B5-4F7E918ED8B0 wds:Q36907216-AC46306F-7986-43FA-A89E-087AB56C5AEF
wdt:P2860
wd:Q36412756 wd:Q43944579 wd:Q27852637 wd:Q27852630 wd:Q44519633 wd:Q48655131 wd:Q28289337 wd:Q70651028 wd:Q71713380 wd:Q34655046 wd:Q38109808 wd:Q53962333 wd:Q40280975 wd:Q40282048 wd:Q34421634 wd:Q36087929 wd:Q24621116 wd:Q34471982 wd:Q42430311 wd:Q73221160 wd:Q37194027 wd:Q36642923 wd:Q77598704 wd:Q36336601 wd:Q34468621 wd:Q29617404 wd:Q37585095 wd:Q39064408 wd:Q37206520 wd:Q24604601 wd:Q27702205 wd:Q64994871 wd:Q37721802 wd:Q29614642 wd:Q73677743 wd:Q29030219 wd:Q29395525 wd:Q36407754
p:P2093
wds:Q36907216-0FDA9473-FBD7-442C-97E8-364ACB5DA6CD wds:Q36907216-095298F4-02A9-4C6F-9564-C94FD104E114 wds:Q36907216-07612F7E-757A-4EB7-BA66-697F3C35CA89 wds:Q36907216-3D42D384-CF43-40C3-8954-6DADD7F59D21 wds:Q36907216-2C03A398-0E4A-4A86-8BFC-9B993ADC042A wds:Q36907216-9A756BF7-825F-4FA7-B882-2D618C8D7883 wds:Q36907216-9F133F3E-6293-4BD3-9059-0352D82BE750 wds:Q36907216-93075BB1-3196-465D-A477-92A6E81750ED wds:Q36907216-72224FCF-B550-4F44-8310-F3B910E8BDE3 wds:Q36907216-E931874C-A75D-43B8-AA3D-A88149B51189 wds:Q36907216-E8B231DE-DD08-45A1-B73F-38D7C4D485C3 wds:Q36907216-E3096F49-59AF-438A-86D7-81E2E0F54A6E wds:Q36907216-D1A6492C-555B-4960-A872-BCA721DE8CFF wds:Q36907216-CF251126-7A94-4FEA-8DC9-C582E0BF42C0 wds:Q36907216-CA526F28-C3A2-4333-BC86-A827841384E3 wds:Q36907216-AC478B61-A777-488B-8F33-1485EE93883C
wdt:P2093
Junko Aimi Heidi Savage Meng Chen Lukas C Amler Kimberly Walter Steven Gendreau Timothy R Wilson Peter Schmid Jill M Spoerke Garret M Hampton Mark R Lackner Jiaheng Qiu Stephen Johnston Iris T Chan Ian Krop Mika K Derynck
rdfs:label
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
skos:prefLabel
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
schema:name
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
p:P1476
wds:Q36907216-49D234CC-CD20-45EB-AE11-4168A0951BA7
wdt:P1476
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
p:P304
wds:Q36907216-EA8A51FF-D9E3-4A0D-8966-46CE086BE933
wdt:P304
11579
p:P31
wds:Q36907216-F5FA7A07-DFFF-4BC7-A2A1-35CF3F992462
wdt:P31
wd:Q13442814
p:P921
wds:Q36907216-EAD63AD9-12C7-444B-9B27-449C95015B76
wdt:P921
wd:Q12859063
p:P698
wds:Q36907216-A7E12365-7B8E-4CA4-839D-66858C47BA3D
wdtn:P698
n11:27174596
wdt:P698
27174596
p:P1433
wds:Q36907216-7EBCCDE2-2033-4490-BAE1-CE0ED174746D
wdt:P1433
wd:Q573880
p:P478
wds:Q36907216-5B2F7234-51B2-4F25-8CF9-D21F41899A7C
wdt:P478
7
p:P356
wds:Q36907216-08610D07-119D-4648-B8AD-4967AE07B9A5
wdtn:P356
n13:NCOMMS11579
wdt:P356
10.1038/NCOMMS11579
p:P275
wds:Q36907216-0fe1d148-656d-4dca-aa43-2d44761cdb44
p:P6216
wds:Q36907216-9ab6d8a8-fb86-4347-8333-ae396d3741e4
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P819
wds:Q36907216-433F8536-B699-4705-84B4-1CE0303B005E
wdt:P819
2016NatCo...711579S
p:P932
wds:Q36907216-56083351-4E32-41CA-8FA5-9D0673B1FA83
wdt:P932
4869259